Anti-PDCD1/PD-1/CD279 Antibody (Toripalimab)
Catalog No.
F1337
Anti-PDCD1/PD-1/CD279 Antibody (Toripalimab)
Featured Products
Toripalimab is the first domestically produced anti-tumorPD-1 Antibody. Toripalimab is a targetedPD-1 Toripalimab is a selective humanized monoclonal antibody.PD-1 Toripalimab binds to and blocks the interaction with its ligand. Toripalimab has a potent anti-tumor effect and can be used in the study of tumors such as melanoma, lung cancer, digestive tract tumors, hepatobiliary and pancreatic tumors, neuroendocrine tumors, nasopharyngeal carcinoma and urothelial carcinoma.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
147.3 kDa
Dry ice
1924598-82-2
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
JS-001, Triprizumab, Treprilimab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q15116
Human
Unconjugated
Monoclonal
Protein A
IgG4
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human PD-1, His Tag at 2 ug/mL can bind Anti-PDCD1/PD-1/CD279 Antibody (Toripalimab)
PDCD1 / PD-1 / CD279
Please avoid freeze-thaw cycles.